XML 92 R73.htm IDEA: XBRL DOCUMENT v3.26.1
LICENSE AND SECURITIES PURCHASE AGREEMENTS - AYRMID/HIGHBRIDGE (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2024
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
License And Securities Purchase Agreements [Line Items]          
Consideration received $ 19,000        
License revenues     $ 1,180 $ 22,917 $ 4,610
Ayrmid License Agreement [Member]          
License And Securities Purchase Agreements [Line Items]          
Upfront Payment 10,000        
Consideration received 7,800        
License revenues   $ 7,800      
Total royalties based on motixafortide net sales     $ 1,200    
Ayrmid License Agreement [Member] | Single Material Performance Obligation [Member]          
License And Securities Purchase Agreements [Line Items]          
Consideration received 7,800        
Highbridge [Member]          
License And Securities Purchase Agreements [Line Items]          
Gross proceeds from offering 9,000        
Registered Direct Offering [Member]          
License And Securities Purchase Agreements [Line Items]          
Consideration received 11,200        
Costs incurrent in offering $ 100        
Bottom of range [member] | Ayrmid License Agreement [Member]          
License And Securities Purchase Agreements [Line Items]          
Percentage of royalties receivable from aggregate net sales 18.00%        
Top of range [member] | Ayrmid License Agreement [Member]          
License And Securities Purchase Agreements [Line Items]          
Upfront Payment $ 87,000        
Percentage of royalties receivable from aggregate net sales 23.00%